Rising investment in developing novel products by market players for drug abuse is a factor driving the global drugs of abuse testing market, says Fortune Business Insights in a report, titled Drugs Of Abuse Testing Market Size, Share and Global Trend
- Immunoassay Analyzers
- Chromatography Instruments
- Breath Analyzers
- Rapid Test Kits
By Sample Type
- Medical Screening
- Monitoring Pain Management
- Forensic & Legal Information
- Employment Drug Testing
- Sports & Athletics Testing
- Forensic Labs
- Diagnostic Centres
- Speciality Clinics
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Implmentation of Stringent Regulations by Government Will Facilitate Growth
The rising technological advancements in analyzers for multidrug detection is driving the global drugs of abuse testing market. The growing trend of medical screening along with increasing investment by key players in developing novel products for drug abuse screening are factors predicted to augment the drugs of abuse testing market share in the forthcoming year. Furthermore, enhanced stringent regulations by the government for making drug abuse screening obligatory is expected to boost drugs of abuse testing growth during the forecast period.
Availability of On-spot Testing Kits Will Aid Growth in North America
Geographically, the global drugs of abuse testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is presently dominating the global drugs of abuse testing market and is projecting to dominate during the forecast period owing to the strict government regulations for the use of prohibited drugs and the increasing availability of on-spot testing kits.
Some of the major companies that are present in the global drugs of abuse testing market are Siemens Healthcare GmbH, Abbott, Thermo Fisher Scientific Inc., LifeSign LLC., MP Biomedicals, Premier Biotech, Inc., MEDACX Ltd., Chromsystems Instruments & Chemicals GmbH, AccuBioTech Co. Ltd., Screen Italia Srl, Paramedical s.r.l., and others.
More Trending Topics From Fortune Business [email protected]
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.